Abstract
The emergence of multidrug-resistant strains of Mycobacterium tuberculosis is posing a problem worldwide, indicating a need for renewed efforts in drug development. Researchers at the Global Conference on Lung Health [Mainz, Germany; June 1994] described the potential of new drugs currently in preclinical development, and the possibility of speeding up recovery using a killed Mycobacterium vaccae preparation.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Higgins, G. Research efforts in the continuing fight against tuberculosis. Inpharma Wkly. 946, 9–10 (1994). https://doi.org/10.2165/00128413-199409460-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199409460-00017